Compile Data Set for Download or QSAR
Report error Found 152 Enz. Inhib. hit(s) with all data for entry = 10945
TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580337(US11498930, Compound 1.2.34 | (R)-8-(8-((3-amino-2...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580291(US11498930, Compound 1.2.7 | (1-(8-((2,3-dichlorop...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580300(US11498930, Compound 1.2.14 | (S)-8-(8-((2,3-dichl...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580305(US11498930, Compound 1.2.18 | (1R)-8-(8-((2,3-dich...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580301(US11498930, Compound 1.2.15 | (R)-8-(8-((2,3-dichl...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580306(US11498930, Compound 1.2.19 | (3S,4S)-8-(8-((2,3-d...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580361(US11498930, Compound 1.2.57 | (3S,4S)-8-(8-((2,3-d...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580362(US11498930, Compound 1.2.58 | (3S,4S)-8-(8-((3-chl...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580359(US11498930, Compound 1.2.55 | (S)-8-(8-((6-amino-2...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580367(US11498930, Compound 1.2.61 | (3S,4S)-8-(8-((6-ami...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580368(US11498930, Compound 1.2.62 | (3R,4S)-8-(8-((3-chl...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580363(US11498930, Compound 1.2.59 | (3S,4S)-8-(8-((2-ami...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580364(US11498930, Compound 1.2.60 | (3S,4S)-8-(8-((2-ami...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM527826((1-(8-((2,3- dichlorophenyl)thio) imidazo[1,2- c]p...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM527827((R)-8-(8-((2,3- dichlorophenyl)thio) imidazo[1,2- ...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580202(US11498930, Compound 1.1.12 | (1R)-8-(8-((2,3-dich...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580199(US11498930, Compound 1.1.9 | (S)-8-(8-((2,3-dichlo...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580346(US11498930, Compound 1.2.42 | (R)-8-(8-((6-amino-2...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580343(US11498930, Compound 1.2.39 | (R)-8-(8-((3-chloro-...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580350(US11498930, Compound 1.2.46 | (R)-8-(8-(naphthalen...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580347(US11498930, Compound 1.2.43 | (R)-8-(8-((2,3-dichl...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580354(US11498930, Compound 1.2.50 | (1R)-8-(8-((2,3-dich...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580351(US11498930, Compound 1.2.47 | (R)-8-(8-(quinolin-4...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580355(US11498930, Compound 1.2.51 | (1R)-8-(8-((2-amino-...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580356(US11498930, Compound 1.2.52 | (1R)-8-(8-((6-amino-...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM527830((R)-8-(8-((3-chloro-2- methylpyridin-4- yl)thio)im...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580227(US11498930, Compound 1.1.32 | (R)-8-(8-((3-chloro-...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580224(US11498930, Compound 1.1.29 | (R)-8-(8-((3-chloro-...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580225(US11498930, Compound 1.1.30 | (R)-8-(8-((3-chloro-...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM527829((R)-8-(8-((2,3- dichloropyridin-4- yl)thio)imidazo...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580232(US11498930, Compound 1.1.36 | (R)-8-(8-((2-methylp...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580228(US11498930, Compound 1.1.33 | (R)-8-(8-((2-amino-5...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580229(US11498930, Compound 1.1.34 | (R)-8-(8-((6-amino-2...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580236(US11498930, Compound 1.1.39 | (R)-8-(8-((6-amino-2...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580238(US11498930, Compound 1.1.40 | (R)-8-(8-((2-chlorop...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580234(US11498930, Compound 1.1.37 | (R)-8-(8-((2-(triflu...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580235(US11498930, Compound 1.1.38 | (R)-8-(8-((2-chlorop...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580242(US11498930, Compound 1.1.43 | (R)-8-(8-((1-methyl-...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM527838((3S,4S)-8-(8- ((2,3- dichlorophenyl) thio)imidazo[...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580206(US11498930, Compound 1.1.16 | (3S,4S)-8-(8-((6-ami...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580203(US11498930, Compound 1.1.13 | (1R)-8-(8-((2,3-dich...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580204(US11498930, Compound 1.1.14 | (4R)-4-amino-8-(8-((...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580209(US11498930, Compound 1.1.19 | (R)-8-(8-((2-chlorop...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580214(US11498930, Compound 1.1.22 | (R)-8-(8-((2-methoxy...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580222(US11498930, Compound 1.1.27 | (R)-8-(8-((3-(triflu...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580223(US11498930, Compound 1.1.28 | (R)-8-(8-((3-chloro-...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM527828((R)-8-(8-((2-amino- 3-chloropyridin-4- yl)thio)imi...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580274(US11498930, Compound 1.1.63 | (S)-8-(8-((6-amino-3...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580276(US11498930, Compound 1.1.64 | (3S,4S)-8-(8-((2-ami...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

TargetTyrosine-protein phosphatase non-receptor type 11(Human)
Blueray Therapeutics (Shanghai)

US Patent
LigandPNGBDBM580272(US11498930, Compound 1.1.61 | (R)-8-(8-((6-amino-3...)
Affinity DataIC50: 100nMAssay Description:Compound powders were dissolved in DMSO to prepare mother liquor.During the experiment, the stock solutions of the compounds were subjected to 3-fold...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2023
Entry Details
US Patent

Displayed 1 to 50 (of 152 total ) | Next | Last >>
Jump to: